Of interest, this dual role of TGFβ in the TME is observed when at low doses facilitates NK cell recruitment to the tumor by up-regulating CXCR4 and CXCR3, markers of dNK; and at high doses, down-regulates NKp30, limiting NK killer activity (41). The gene discussed is TGFB1; the disease is neoplasm.